Chapter 9 diets for preventing hepatic steatosis in hepatic steatosis clinical risk factors molecular mechanisms and treatment outcomes pages 171 208. These studies suggest that patients with nash or nash with fibrosis or cirrhosis are at risk of poor clinical outcomes hepatic steatosis hepatic resection and liver transplantation et al surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults gastroenterology. Hepatic steatosis clinical risk factors molecular mechanisms and treatment outcomes sergio santos home worldcat home about worldcat help search search hepatology research and clinical developments series responsibility sergio santos phd editor reviews user contributed reviews. Racial differences in rates of obesity and diabetes may contribute to racial differences in hepatic steatosis and treatment response 17 despite a higher prevalence of risk factors for nafld clinical series have also found an unexplained low representation of african c ns3 ns5a in hepatic oncogenesis hepatology research 38 1 . Prevalence of and risk factors for hepatic steatosis and nonalcoholic ffatty liver disease in people with type 2 diabetes the edinburgh type 2 diabetes study diabetes care 34 1139 1144 2011
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )